Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novartis discloses updated phase II data on secukinumab

March 22, 2012

Merck & Co. uncovers gene polymorphisms linked to MK-7246 pharmacokinetics

March 22, 2012

Scientists identify new potential biomarker of myxoid/round cell liposarcoma

March 21, 2012

New promising results disclosed on brodalumab in plaque psoriasis

March 21, 2012

Genentech presents PK/PD model for IBD therapy

March 21, 2012

New Pfizer product shows promising anticancer actvity

March 21, 2012

U.S. study links SNPs to complications after subarachnoid hemorrhage

March 20, 2012

New data highlight role of lymphopoietin in chronic rhinosinusitis with nasal polyps

March 20, 2012

Novel first-in-human data presented on Medimmune cancer immunotherapy

March 20, 2012

Phase I trial assesses interaction between diabetes therapies

March 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...